Kenji Okonogi

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

Masanori Baba, Osamu Nishimura, Naoyuki Kanzaki et al. · Proceedings of the National Academy of Sciences · 1999 · 755 citations · Full text

Molecular cloning and nucleotide sequence determination of the regulator region of <i>mecA</i> gene in methicillin‐resistant <i>Staphylococcus aureus</i> (MRSA)

Keiichi Hiramatsu, Kazumi Asada, Eiko Suzuki et al. · FEBS Letters · 1992 · 182 citations

Formation of Azole-Resistant <i>Candida albicans</i> by Mutation of Sterol 14-Demethylase P450

Kentaro Asai, Noboru Tsuchimori, Kenji Okonogi et al. · Antimicrobial Agents and Chemotherapy · 1999 · 102 citations

Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice

Yuji Iizawa, Kenji Okonogi, Rina Hayashi et al. · Antimicrobial Agents and Chemotherapy · 1993 · 89 citations · Full text

Experimental Infections, Therapeutic Effect, Health Sciences +14

In vitro antimicrobial activity of T-91825, a novel anti-MRSA cephalosporin, and in vivo anti-MRSA activity of its prodrug, TAK-599

Yuji Iizawa, Junko Nagai, Tomoyasu Ishikawa et al. · Journal of Infection and Chemotherapy · 2004 · 84 citations

Vivo Anti-mrsa Activity, Antibiotics, Medicine +10